Placebo for Icalcaprant

DRUG2 trials

Sponsors

AbbVie

Conditions

Bipolar I DisorderBipolar II DisorderMajor Depressive Disorder

Phase 2

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

RecruitingNCT06696755

AbbVieBipolar I Disorder, Bipolar II Disorder

Start: 2026-02-03End: 2027-11-01Target: 195Updated: 2026-04-03

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

RecruitingNCT07276997

AbbVieMajor Depressive Disorder

Start: 2025-12-18End: 2027-09-01Target: 195Updated: 2026-03-23